Facebook
Twitter
Telegram
Report an ErrorKintara Therapeutics Balance Sheet 2011-2024 | KTRA
Annual Balance Sheet Kintara Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
- | - | - | -182 M | -3.72 M | -5.97 M | -6.59 M | -6.16 M | -1.75 M | - | -3.86 M | -1.79 K | -5.7 K |
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | 272 K | - | - |
Long Term Debt Current |
- | - | - | - | - | - | 33.1 K | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | 1.12 K | 28.1 K | 870 K | 1.21 M | - | 4.89 M | - | - |
Total Current Liabilities |
3.08 M | 3.99 M | 2.78 M | - | - | 1.64 M | 1.3 M | 627 K | 853 K | 300 K | 249 K | 1.13 M | - |
Total Liabilities |
3.25 M | 4.15 M | 2.96 M | - | 2.07 M | 1.64 M | 1.33 M | 1.5 M | 2.06 M | - | 5.14 M | 9.98 K | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-151 M | -136 M | -111 M | - | -60.6 M | -52.4 M | -41.1 M | -32.2 M | -23.5 M | - | -15.9 M | -57.6 K | -38.7 K |
Total Assets |
3.98 M | 15.9 M | 13.5 M | 182 M | 4.04 M | 7.07 M | 7.91 M | 6.36 M | 2.58 M | - | 4.32 M | 1.79 K | 10.7 K |
Cash and Cash Equivalents |
1.54 M | 11.8 M | 10.5 M | 2.39 M | 3.72 M | 5.97 M | 6.59 M | 6.16 M | 1.75 M | 4.76 M | 4.14 M | 17.8 K | 15 K |
Book Value |
731 K | 11.8 M | 10.6 M | 182 M | 1.97 M | 5.44 M | 6.58 M | 4.86 M | 512 K | - | -818 K | -8.19 K | 10.7 K |
Total Shareholders Equity |
731 K | 11.8 M | 10.6 M | 263 K | 1.97 M | 5.44 M | 6.58 M | 4.86 M | -821 K | -901 K | -818 K | -1.33 M | -877 K |
All numbers in USD currency
Quarterly Balance Sheet Kintara Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 265 | 76 | 1.34 K | 76 | 1.34 K | 5.45 K | 4.07 K | 5.45 K | 249 K | 171 K | 590 K | 694 K | 1.02 M | 1.35 M | - | 1.02 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
1.52 M | 2.05 M | 3.5 M | 2.95 M | 3.32 M | 3.59 M | 4.15 M | 3.41 M | 3.62 M | 3.18 M | 2.96 M | 2.74 M | 2.9 M | 2.58 M | 2.68 M | 2.68 M | 1.03 M | 1.34 M | 2.07 M | 2.07 M | 1.27 M | 1.08 M | 1.64 M | 1.64 M | 2.23 M | 1.53 M | 1.33 M | 1.33 M | 892 K | 1.07 M | 1.5 M | 1.5 M | 2.07 M | 3.55 M | 3.4 M | 3.4 M | 2.04 M | 3.98 M | 5.91 M | 4.12 M | 5.14 M | 5.7 M | 14.2 M | 5.14 M | 1.51 M | 1.51 M | 1.51 M | 1.51 M | 4.88 K | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-158 M | -156 M | -155 M | -148 M | -145 M | -141 M | -136 M | -131 M | -126 M | -120 M | -111 M | -104 M | -97.8 M | -92.4 M | -69.7 M | -69.7 M | -63.9 M | -62.2 M | -60.6 M | -60.6 M | -56.3 M | -54.5 M | -52.4 M | -52.4 M | -47 M | -43.8 M | -41.1 M | -41.1 M | -36.3 M | -34.8 M | -32.2 M | -32.2 M | -22.9 M | -20.2 M | -18.6 M | -18.6 M | -16.4 M | -15.8 M | -14.3 M | - | - | - | - | - | - | - | - | -56.6 K | -53.5 K | -42.6 K | -38.7 K | -38.7 K |
Total Assets |
7.45 M | 1.88 M | 1.48 M | 6.74 M | 9.92 M | 13.2 M | 15.9 M | 12.8 M | 17.7 M | 22.3 M | 13.5 M | 18.9 M | 20.5 M | 23.1 M | 2.94 M | 2.94 M | 6.51 M | 8.36 M | 4.04 M | 4.04 M | 4.04 M | 4.75 M | 7.07 M | 7.07 M | 12.2 M | 14.4 M | 7.91 M | 7.91 M | 3.59 M | 5.05 M | 6.36 M | 6.36 M | 2.18 M | 2.58 M | 2.58 M | - | 4.13 M | 4.5 M | 5 M | 5 M | 4.32 M | 5.39 M | 6.52 M | 4.32 M | 183 K | 183 K | 183 K | 183 K | 805 | 6.84 K | 10.7 K | 10.7 K |
Cash and Cash Equivalents |
6.35 M | 658 K | 216 K | 3.04 M | 4.87 M | 7.08 M | 11.8 M | 8.84 M | 14.1 M | 19.3 M | 10.5 M | 15.7 M | 17.2 M | 22.6 M | 2.39 M | 2.39 M | 6.35 M | 8.06 M | 3.72 M | 3.72 M | 3.7 M | 3.88 M | 3.7 M | 3.88 M | 11 M | 13.2 M | 11 M | 13.2 M | 3.42 M | 4.8 M | 3.42 M | 4.8 M | 1.96 M | 2.8 M | 1.96 M | 2.8 M | 3.96 M | 4.32 M | 3.96 M | 4.32 M | 4.14 M | 5.17 M | 6.28 M | 4.14 M | 17.8 K | 17.8 K | 17.8 K | 17.8 K | 15 K | 6.84 K | 805 | 5.7 K |
Book Value |
5.92 M | -164 K | -2.03 M | 3.79 M | 6.6 M | 9.62 M | 11.8 M | 9.39 M | 14.1 M | 19.2 M | 10.6 M | 16.1 M | 17.6 M | 20.6 M | 263 K | 263 K | 5.48 M | 7.02 M | 1.97 M | 1.97 M | 2.77 M | 3.67 M | 5.44 M | 5.44 M | 9.98 M | 12.9 M | 6.58 M | 6.58 M | 2.7 M | 3.97 M | 4.86 M | 4.86 M | 117 K | -971 K | -821 K | -3.4 M | 2.09 M | 521 K | -901 K | 880 K | -818 K | -304 K | -7.71 M | -818 K | -1.33 M | -1.33 M | -1.33 M | -1.33 M | -4.08 K | 6.84 K | 10.7 K | 10.7 K |
Total Shareholders Equity |
5.92 M | -164 K | -2.03 M | 3.79 M | 6.6 M | 9.62 M | 11.8 M | 9.39 M | 14.1 M | 19.2 M | 10.6 M | 16.1 M | 17.6 M | 17.6 M | 17.6 M | 20.6 M | 5.48 M | 5.48 M | 5.48 M | 7.02 M | 2.77 M | 3.67 M | 2.77 M | 3.67 M | 9.98 M | 12.9 M | 6.58 M | 6.58 M | 2.7 M | 3.97 M | 4.86 M | 4.86 M | 117 K | -515 K | -821 K | -821 K | 2.09 M | 521 K | -901 K | 880 K | -818 K | -304 K | -12.8 M | -818 K | -1.33 M | -1.33 M | -1.33 M | -1.33 M | -877 K | 6.84 K | -4.08 K | 10.7 K |
All numbers in USD currency